Apple says it supports 2.4 million U.S. jobs
By Stephen Nellis (Reuters) - Apple Inc said on Wednesday it was either directly or indirectly responsible for 2.4 million U.S. jobs, up 20% from the 2 million the technology company estimated in 2017
By Stephen Nellis
(Reuters) - Apple Inc
The iPhone maker said its direct workforce grew from 80,000 to 90,000 in the 2-1/2 years since its last U.S. job estimate. But most of the estimated growth came from companies such as Broadcom Inc
App-related jobs totalled 1.9 million, up by 325,000 from its previous estimate, the Cupertino, California-based company said in a news post on its website.
Apple did not say how it arrived at its estimates or how the research was funded. Estimates of indirect job creation can vary widely depending on how the analysis is carried out.
Apple has faced criticism, including from U.S. President Donald Trump, for contracting factories to assemble most of its products in China. Apple has countered that it spent $60 billion on products and services from U.S.-based suppliers in 2018 and plans to increase that to $350 billion by 2023.
Apple said in December it would spend $1 billion to build a new campus in Austin, Texas, for up to 15,000 employees and that it was adding direct jobs in Seattle, San Diego and Culver City, California.
(Reporting by Stephen Nellis in San Francisco; Editing by Richard Chang)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.